Health
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease – The Conversation UK
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…
Continue Reading
-
Noosa News22 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General15 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News16 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News23 hours agoFrank Moneger identified as man accused of hit-and-run death of 17-year-old girl in Margate, Queensland